Days
Hours
Min
Sec
Conference proceeding full-length article publication in Scopus Journal
Secure your Slot at the forefront of innovation register now to join leading experts and trailblazers in the industry
Join leading experts in the field and contribute to groundbreaking discussions.
Israel.
h-index
Citations
Dr. Yehuda Shoenfeld is a distinguished immunologist and physician known for his groundbreaking research in autoimmunity. He is the founder and former head of the Zabludowicz Center for Autoimmune Diseases at Sheba Medical Center, Israel, and has significantly contributed to understanding autoimmune disorders. With over 2,000 scientific publications, including more than 25 books, Dr. Shoenfeld is one of the most cited researchers in immunology. His research has focused on the mechanisms and triggers of autoimmune diseases, including infections, environmental factors, and vaccines. He has introduced concepts such as the "Autoimmune Syndrome Induced by Adjuvants" (ASIA), which explores the role of vaccine adjuvants in immune responses. Dr. Shoenfeld has held prestigious academic positions, including at Tel Aviv University, and has received multiple international awards for his contributions to immunology. He has also served as the editor-in-chief of key medical journals in the field. His work continues to shape autoimmune disease research, influencing both clinical practice and public health policies.
China
h-index
Citations
Dr. Ren earned his Ph.D. from University of Alberta, Canada, in physiology, following his medical training in China (Beijing University and Peking Union Medical College). Following a 22-year tenure as a professor in various universities in US (University of North Dakota, University of Wyoming and University of Washington), he serves as a professor in Dept of Cardiology at Zhongshan Hospital Fudan University. His major area of research is related to cardiovascular pathophysiology in alcoholism, diabetes, obesity and aging. He has authored more than 700 peer-reviewed papers (H index=117) and is a Clarivate highly cited scholar for the past few years.
Dear Esteemed Attendees, Distinguished Speakers, and Honored Guests,
It is with great pleasure and enthusiasm that I extend a warm welcome to all of you at the 2nd Edition of the World Congress on Pharmaceutical Research and Biotechnology, scheduled to take place on September 4–5, 2025, in Shanghai, China. This prestigious gathering serves as a dynamic platform for experts, researchers, and industry leaders from across the globe to engage in insightful discussions, share groundbreaking research, and foster collaborations that will shape the future of pharmaceutical research and biotechnology.
The theme of this year’s conference, "Emerging Technologies in Pharmaceutical Biotechnology," highlights the transformative impact of cutting-edge innovations such as AI, CRISPR, and synthetic biology in advancing drug discovery, personalized medicine, and biopharmaceuticals. The integration of these revolutionary technologies is paving the way for more efficient, safer, and sustainable healthcare solutions, addressing some of the most pressing global health challenges of the modern era.
This conference provides an invaluable opportunity to engage with leading scientists, regulatory experts, and industry pioneers through cutting-edge research presentations, interactive panel discussions, and networking sessions. From addressing regulatory complexities to exploring market access and the future of AI-driven pharmaceutical advancements, this event is designed to facilitate meaningful knowledge exchange and collaboration.
I encourage all participants to take full advantage of the diverse opportunities this conference offers, whether through presenting innovative research, engaging in thought-provoking discussions, or building lasting professional connections. The insights gained and partnerships formed during these two days will undoubtedly contribute to the continued progress of pharmaceutical research and biotechnology, ultimately benefiting patients and communities worldwide.
Once again, I welcome you all to this esteemed gathering and look forward to an enriching and inspiring event. Let us collectively drive innovation, expand scientific frontiers, and work towards a healthier and more sustainable future.
Italy
Dear Participants, participants and colleagues
It is with great pleasure that we welcome you to the 2nd edition of the World Congress on Pharmaceutical Research and Biotechnology.
A meeting between university researchers in the field of design and discovery of active molecules and the study of their activities, drug development specialists, researchers in the field of biotechnology and bioinformatics, specialist doctors, pharmacists, health and industrial experts.
This meeting is an excellent opportunity for exchange and collaboration. It brings together several qualified experts and enriches our skills.
This combination of academic and industrial skills promotes the emergence of new ideas and approaches and interdisciplinary discussions.
The presence of specialist doctors, pharmacists and health experts can provide feedback on the clinical application of new drugs, the benefits and side effects of these drugs. This helps guide researchers and manufacturers to work together to reduce the side effects of new synthesized drugs. In addition, collaboration can also accelerate the process of discovering and bringing new active molecules and new medical technologies to market.
This type of meeting creates an environment conducive to future partnerships. The exchange of ideas, the pooling of resources and the building of strong professional networks. I am delighted to meet with you for the sake of advancing global health together.
Tunisia
Focus: This session will explore the latest innovations and methodologies in drug discovery and development, from initial target identification to clinical trials.
Key Topics:
Importance: Keeping up with advancements in drug discovery and development is crucial for developing new, effective therapies and staying competitive in the pharmaceutical industry.
Speakers: Industry leaders, academic researchers, and regulatory experts
Focus: Highlighting the latest breakthroughs in biotechnology, this session will cover technologies that are transforming healthcare, agriculture, and environmental management.
Key Topics:
Importance: Understanding and leveraging new biotechnological tools can drive innovation across various sectors, leading to more effective treatments and sustainable practices.
Speakers: Biotechnologists, molecular biologists, and bioengineers
Focus:
This session will delve into the development, production, and application of biologic drugs, emphasizing their role in modern medicine. The session will explore the scientific, technical, and regulatory aspects of biopharmaceuticals, providing a comprehensive understanding of the current landscape and future directions.
Key Topics:
Importance:
Biopharmaceuticals represent a significant advancement in medical treatment, offering targeted therapies for various conditions with the potential for higher efficacy and fewer side effects compared to traditional drugs. Understanding the development and application of these biologics is crucial for healthcare professionals and researchers aiming to improve patient outcomes.
Speakers: Leading experts in biopharmaceutical development, including biotechnologists, clinical researchers, regulatory specialists, and industry leaders.
Focus:
Focusing on advancements in drug formulation and delivery systems, this track will discuss how new technologies are improving drug efficacy and patient outcomes.
Key Topics:
Importance:
Effective drug delivery systems are essential for ensuring that therapies reach their targets in the body efficiently and safely, which is crucial for patient treatment success.
Speakers: Pharmaceutical scientists, formulation experts, and biomedical engineers
Focus: This track will explore how bioinformatics and big data are revolutionizing research in biotechnology, enabling new discoveries and personalized approaches to treatment.
Key Topics:
Importance: The integration of data-driven approaches in biotechnology is leading to more precise and personalized treatments, accelerating research and development in the field.
Speakers: Bioinformaticians, data scientists, and computational biologists
Focus: This track will address the latest trends and ethical challenges in pharmaceutical research and biotechnology, emphasizing the need for responsible innovation.
Key Topics:
Importance: Understanding the ethical and societal impacts of scientific advancements is crucial for ensuring responsible and sustainable development in pharmaceutical and biotechnological research.
Speakers: Ethicists, policymakers, and industry experts
University of Carthage
Tunisia
Shanghai Jiao Tong University
China
Pasteur Institute of Iran
Iran, Islamic Republic of
Jilin University
China
| Time | Schedule Overview |
|---|---|
| 08:00 - 09:00 | Registration and Welcome Coffee |
| 09:00 - 09:30 | Opening Ceremony |
| 09:30 - 10:10 | Keynote Session |
| 10:10 - 10:30 | Q&A Session |
| 10:30 - 11:00 | Morning Coffee Break & Exhibitor Interaction |
| 11:00 - 12:30 | Presentations |
| 12:30 - 13:30 | Networking Lunch |
| 13:30 - 14:30 | Presentations |
| 14:30 - 15:00 | Panel Discussion |
| 15:00 - 15:30 | Afternoon Coffee & Break & Networking |
| 15:30 - 16:30 | Presentations |
| 16:30 - 17:00 | Industry Forums Delegate-Led Discussions |
| 17:00 - 18:00 | Poster Presentations |
| Time | Schedule Overview |
|---|---|
| 08:00 - 09:00 | Registration and Welcome Coffee |
| 09:00 - 10:00 | Keynote Session 2 |
| 09:40 - 10:00 | Q&A Session |
| 10:00 - 11:00 | Presentations |
| 11:00 - 11:30 | Morning Coffee Break & Networking |
| 11:30 - 13:00 | Presentations |
| 13:00 - 14:00 | Networking Lunch |
| 14:00 - 15:00 | Presentations |
| 15:00 - 15:30 | Panel Discussion |
| 15:30 - 16:00 | Afternoon Coffee & Break & Networking |
| 16:00 - 17:00 | Student Doctorial Program |
| 17:00 - 17:30 | Award Ceremony & Photo Session |
| 17:30 - 18:00 | Conference Close and Farewell Networking |
Step into the forefront of innovation and discovery at USF Pharmaceutical Research & Biotechnology Event, China, where leading minds in science and research converge to share their latest findings, engage in thought-provoking discussions, and collaborate on shaping the future of Pharmaceutical Research & Biotechnology.
** We won't spam you!
